- Home
- INO vs UAMY Comparison
INO vs UAMY Comparison
Compare INO & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- UAMY
- Stock Information
- Founded
- INO 1979
- UAMY 1968
- Country
- INO United States
- UAMY United States
- Employees
- INO N/A
- UAMY N/A
- Industry
- INO Medical/Dental Instruments
- UAMY Metal Fabrications
- Sector
- INO Health Care
- UAMY Industrials
- Exchange
- INO Nasdaq
- UAMY Nasdaq
- Market Cap
- INO 75.4M
- UAMY 74.2M
- IPO Year
- INO 1998
- UAMY N/A
- Fundamental
- Price
- INO $2.08
- UAMY $1.65
- Analyst Decision
- INO Buy
- UAMY Strong Buy
- Analyst Count
- INO 6
- UAMY 2
- Target Price
- INO $17.00
- UAMY $1.75
- AVG Volume (30 Days)
- INO 1.2M
- UAMY 3.3M
- Earning Date
- INO 03-05-2025
- UAMY 11-12-2024
- Dividend Yield
- INO N/A
- UAMY N/A
- EPS Growth
- INO N/A
- UAMY N/A
- EPS
- INO N/A
- UAMY N/A
- Revenue
- INO $203,413.00
- UAMY $10,219,826.00
- Revenue This Year
- INO N/A
- UAMY $62.73
- Revenue Next Year
- INO $2,290.97
- UAMY $194.39
- P/E Ratio
- INO N/A
- UAMY N/A
- Revenue Growth
- INO N/A
- UAMY 28.40
- 52 Week Low
- INO $1.74
- UAMY $0.17
- 52 Week High
- INO $14.75
- UAMY $2.35
- Technical
- Relative Strength Index (RSI)
- INO 39.63
- UAMY 51.38
- Support Level
- INO $1.83
- UAMY $1.43
- Resistance Level
- INO $2.39
- UAMY $1.87
- Average True Range (ATR)
- INO 0.17
- UAMY 0.15
- MACD
- INO 0.11
- UAMY -0.04
- Stochastic Oscillator
- INO 51.56
- UAMY 33.85
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.